General Medicine Year in Review 2011

Home>
Specialties>
General Medicine>
Letter to Readers

General Medicine Year in Review 2011

The most important medical topics of 2011, as chosen by the editors of Journal Watch General Medicine

Each year, the editors of Journal Watch General Medicine choose the year's most important thematic areas in clinical research. We try to strike a balance between relevance to primary care, recognition of landmark studies, and media publicity and public awareness. Some of our stories emerge from one important study, and others come from several studies on a single topic. The order of these stories is not intended to reflect their relative importance.

OUR YEAR IN REVIEW TOPICS FOR 2011:

USPSTF Recommends Against Prostate Cancer Screening

Screening for Lung Cancer: Radiography? No. Low-Dose CT? Maybe.

Ovarian Cancer Screening: No Effect on Mortality

New Hepatitis C Drugs Improve Genotype 1 Response Rates

Risk Stratification for CAD: What's Worth Doing?

Aspirin for Preventing Colorectal Cancers and Other Solid Tumors

Selective and Nonselective NSAIDs Are Associated with Excess Cardiovascular Risk

Atypical Femur Fractures with Bisphosphonates

Supplementation with Niacin or ${omega}$ -3 Fatty Acids Is Ineffective for Secondary Prevention

Which Strategies Are Best for Measuring BP and Diagnosing Hypertension?

Intermittent Budesonide in Preschool Children with Recurrent Wheezing

Three More Topics That Drew Our Attention in 2011

— Allan S. Brett, MD, Editor-in-Chief, and the JW General Medicine Associate Editors

Published in Journal Watch General Medicine December 29, 2011

Reader Remarks:

Review and add to remarks on this article

looking forward a better future
Hu Hao, 4 Jan 2012 3:01 PM EST
Specialty: Cardiovascular Disease
Every year there are a lot of fantastic researches with most clinic relevance emerge. We are glad to see these... [more]

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

The editors of Journal Watch may respond to Reader Remarks, but we cannot promise to respond to a particular remark.

Remark subject:*

Your remark:*

Fields marked with an * are required.

Name as you'd like it to appear:
First & middle initial:*

Last:*

Email address (will not
be published):*

Professional specialty:*

Place of work (optional):

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

No competing interests

Or, the following competing interests (for example, financial stakes or professional relationships):

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.